Equities
  • Price (CHF)44.68
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change--
  • Beta1.1158
Data delayed at least 15 minutes, as of Jun 24 2019 16:16 BST.
More ▼

Announcements

    Key statistics

    On Monday, Novozymes A/S (NZYMB:SWX) closed at 44.68, 4.08% above its 52-week low of 42.93, set on Feb 04, 2019.
    52-week range
    Today
    42.93Feb 04 201951.98Oct 18 2018
    Markit short selling activity
    Low
    Med
    High
    Open0.00
    High--
    Low--
    Bid--
    Offer--
    Previous close44.68
    Average volume--
    Shares outstanding237.26m
    Free float159.48m
    P/E (TTM)26.52
    Market cap70.39bn DKK
    EPS (TTM)11.19
    DKK
    Annual div (ADY)0.7608
    CHF
    Annual div yield (ADY)1.70%
    Div ex-dateFeb 28 2019
    Div pay-dateMar 04 2019
    Data delayed at least 15 minutes, as of Jun 24 2019 16:16 BST.
    More ▼
    The Financial and Risk business of Thomson Reuters is now Refinitiv
    All markets data located on FT.com is subject to the FT Terms & Conditions
    All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
    Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
    Markit Short Selling Activity © Markit. All rights reserved.
    Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.